Nxera Pharma Reports Third-Quarter 2026 Results
Nxera Pharma published operational highlights and consolidated results for the third quarter of 2026.
Related stories
AstraZeneca Reports Third-Quarter Results
M impact | EQUITY | Oct 30, 2026, 07:04 AM UTC
BP Reports Third-Quarter Underlying Replacement-Cost Profit of $8.46 Billion
H impact | EQUITY | Oct 30, 2026, 07:02 AM UTC
Asian session market picture: S&P 500 -0.85%, Nasdaq 100 -1.92%; USD/JPY +0.01%, WTI +0.93%, 1810 leads volume
Asian session market picture. US index futures: S and P futures is down 0.85 percent, Nasdaq futures is down 1.92 percent, Dow futures is unchanged at 0 percent and Russell futures
M impact | EQUITY | Oct 30, 2026, 07:01 AM UTC
KOSPI Falls 3.48% as SK Hynix Drops More Than 6%
The KOSPI fell 3.48% amid foreign investor selling and negative news from the United States. SK Hynix dropped more than 6%.
M impact | EQUITY | Oct 30, 2026, 06:57 AM UTC
ERIE Reports Fiscal Q3 Profit
ERIE reported fiscal third-quarter profit attributable to shareholders, up 3.39% year over year, and basic EPS.
M impact | EQUITY | Oct 30, 2026, 06:53 AM UTC
Japan’s Nikkei falls as much as 3% as chip stocks slide
Japan’s Nikkei share average fell as much as 3% on Friday, led by chip-related stocks, amid concerns about the sustainability of AI spending. The selloff followed overnight Wall St
M impact | EQUITY | Oct 30, 2026, 06:53 AM UTC